It has been recognized that MAPK signaling and PI3K/AKT signaling are usually activated in a variety of human cancers to promote their malignant phenotype, which has also been observed in the functional process of LOXL1-AS1 (Fig. 4). Here, LOXL1 is linked to cancer.